ICU sedation, delirium & recovery

Frailty’s influence on 30-day mortality in old critically ill ICU patients: a bayesian analysis evaluating the clinical frailty scale

Ann Intensive CarePublished Bayesian analysis of pooled data from three international prospective cohort studies

Main findingResult — go to the resultMedian odds ratio 1.60 95% CI 1.45–1.76

Authors' conclusion

This research demonstrates the significant impact of frailty on short-term mortality in critically ill elderly patients, particularly when the Clinical Frailty Scale (CFS) is used as a continuous measure.

Study context

Population
Older critically ill ICU patients (median age 82 years)
Participants
10,363 patients · 3 prospective studies
Exposure
Frail vs non-frail
Outcome
All-cause mortality
Follow-up
30 days
Methodological detailshierarchical Bayesian logistic regression, adjusted for covariables, range of priors, consensus minimal clinically important difference (MCID)
  • Hierarchical Bayesian logistic regression
  • Adjusted for covariables
  • Range of priors
  • Consensus MCID

Main finding

As reported in the abstract

Median odds ratio

1.60

95% CI 1.45–1.76

By group

Frail vs Non-frail
median OR 1.60 (95% CI 1.45–1.76)
Overall 30-day mortality
43%
Probability of adverse effect (OR > 1)
100%
Probability of exceeding MCID (OR > 1.5)
90%

Observational data: associations, not effects.

Further findings

30-day mortality, Clinical Frailty Scale (CFS) as a continuous variable

Median OR (CI)
Clinical Frailty Scale (continuous)Bayesian analysis1.19 (1.16–1.22)
  • 30-day mortality, CFS as a continuous variable: over 99% probability of effect more significant than 1.5 times the MCID

Original publication

Frailty’s influence on 30-day mortality in old critically ill ICU patients: a bayesian analysis evaluating the clinical frailty scale. Ann Intensive Care. Published 13 December 2023. doi:10.1186/s13613-023-01223-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.